Mark A Morgan Selected Research

Mark A Morgan Research Topics

Disease

27	Neoplasms (Cancer) 06/2022 - 06/2005
12	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 02/2002
11	Carcinoma (Carcinomatosis) 01/2021 - 04/2006
7	Endometrial Neoplasms (Endometrial Cancer) 06/2022 - 01/2020
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2002
3	Carcinosarcoma 04/2022 - 09/2020
3	Thrombocytopenia (Thrombopenia) 12/2019 - 04/2003
2	Anemia 12/2022 - 12/2019
2	Neutropenia 12/2022 - 05/2011
2	Ovarian Epithelial Carcinoma 01/2022 - 08/2003
2	Lymphatic Metastasis 09/2021 - 01/2021
2	Leiomyosarcoma 09/2021 - 04/2003
2	Endometrial Stromal Sarcoma 09/2021 - 01/2020
2	Endometrioid Carcinoma 06/2021 - 01/2020
2	Adenocarcinoma 01/2021 - 01/2020
2	Fistula 05/2009 - 11/2004
1	Sarcoma (Soft Tissue Sarcoma) 09/2021
1	Adenosarcoma 09/2021
1	Vulvar Neoplasms (Vulvar Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Adenosquamous Carcinoma 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020
1	Fatigue 12/2019
1	Nausea 12/2019
1	Granulosa Cell Tumor 05/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Cytokine Release Syndrome 01/2017
1	Residual Neoplasm 12/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015
1	Diphtheria 05/2012
1	Bladder Exstrophy (Exstrophy, Bladder) 10/2009
1	Acidosis 10/2009
1	Vesicovaginal Fistula 10/2009
1	Fecal Incontinence 04/2009
1	Fallopian Tube Neoplasms 09/2008
1	Cellulitis 04/2006
1	Wounds and Injuries (Trauma) 04/2006
1	Lymphedema (Milroy Disease) 04/2006
1	Colorectal Neoplasms (Colorectal Cancer) 12/2005
1	Infections 06/2005
1	Pelvic Organ Prolapse 05/2005

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 12/2022 - 02/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 04/2003
4	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 09/2008
2	Peptides (Polypeptides)IBA 01/2020 - 05/2012
2	CreatinineIBA 10/2009 - 04/2003
1	rucaparibIBA 12/2022
1	veliparibIBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	Metronidazole (Metric)FDA LinkGeneric 01/2018
1	Neomycin FDA LinkGeneric 01/2018
1	Vancomycin FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	InterferonsIBA 01/2017
1	MesothelinIBA 01/2017
1	CytokinesIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Mitochondrial DNA (mtDNA)IBA 10/2015
1	VaccinesIBA 10/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2015
1	AZD 6244IBA 02/2013
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 05/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2011
1	paclitaxel poliglumex (XYOTAX)IBA 09/2008
1	insulin receptor-related receptor (IRR)IBA 03/2007
1	Tamoxifen FDA LinkGeneric 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 06/2005
1	Glycoproteins (Glycoprotein)IBA 06/2005
1	Thromboplastin (Tissue Factor)IBA 06/2005
1	Viral DNAIBA 06/2005
1	AntigensIBA 06/2005
1	Dietary Fiber FDA Link 05/2005

Therapy/Procedure

15	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 04/2006
14	Hysterectomy 06/2022 - 01/2020
12	Drug Therapy (Chemotherapy) 12/2022 - 01/2008
10	Therapeutics 04/2022 - 04/2003
8	Radiotherapy 06/2022 - 01/2002
7	Adjuvant Chemotherapy 06/2022 - 01/2019
2	Urinary Diversion (Ileal Conduit) 10/2009 - 05/2009
1	Brachytherapy 06/2022
1	Laparotomy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Minimally Invasive Surgical Procedures 09/2020
1	Salpingo-oophorectomy 01/2020
1	Induction Chemotherapy 12/2019
1	Operative Time 01/2019
1	Aftercare (After-Treatment) 01/2017
1	Cytoreduction Surgical Procedures 12/2016
1	Immunotherapy 10/2015
1	Operative Surgical Procedures 04/2009
1	Ligation 04/2006